Inhibikase Therapeutics, Inc. · NASDAQ:IKT

Perceptive Advisors LLC reported a 6.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Perceptive Advisors LLC reported a 6.90% stake in Inhibikase Therapeutics, Inc., 10,320,875 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.90%
Shares
10,320,875
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC6.90%10,320,875
Joseph Edelman6.90%10,320,875
Perceptive Life Sciences Master Fund, Ltd.6.90%10,320,875

Source

View original at SEC

Related